Accessibility Menu
Mobia Medical logo

Mobia Medical(NASDAQ) MOBI

Current Price$11.03
Market Cap$367.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)-6%
5 YearN/A
1 YearN/A
1 Month-20%
Mobia Medical last closing stock price
MetricPriceDate
Last closeUSD 11.062026-07-22
Mobia Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.43%USD 11.822026-07-15
1 month-20.26%USD 13.872026-06-22
Since inception-5.87%USD 11.752026-05-08

Mobia Medical Financials at a Glance

Market Cap

$367.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.07

Net Income (TTM)

-$17.74

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-2.47 (Low)

Price

$11.03

Volume

3,032

Open

$12.21

Previous Close

$11.03

Daily Range

$11.03 - $12.21

52-Week Range

$10.19 - $15.29

Estimated Earnings Date

Sep 3, 2026

MOBI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mobia Medical

Mobia Medical helps stroke survivors regain use of their limbs. It makes a small implant that stimulates nerves during physical therapy. This treatment helps the brain learn how to move muscles again.

What Mobia Makes for Patients

  • Vivistim System: Implantable pulse generator and lead used to treat chronic ischemic stroke survivors with motor impairments.
  • Vivistim Therapy: Paired Vagus Nerve Stimulation (VNS) that sends electrical pulses during rehab to improve arm and hand function.
  • Clinical Solutions: Clinically-validated medical devices designed to increase neuroplasticity, which is the brain's ability to rewire itself.

A Roadmap for Growth

  • Rebranded from MicroTransponder, Inc. to Mobia Medical, Inc. in February 2026 to reflect its commercial stage.
  • Completed an initial public offering in May 2026, raising approximately $134.5 million in net proceeds.
  • Executed a Series F funding round in 2025 to support the full commercial launch of its stroke recovery technology.
  • Maintained a loan agreement with Horizon Technology Finance Corporation providing up to $30 million in available capital.

How the Technology Stands Out

Mobia holds FDA premarket approval for the only clinically-validated vagus nerve stimulation system dedicated to chronic stroke recovery. The company uses a direct sales force to integrate its therapy into specialized stroke centers and rehabilitation hospitals.

A Look at the Numbers

  • Revenue reached $12.1 million in the first quarter of 2026, up 113% year-over-year.
  • Net loss attributable to common stockholders worsened to $17.7 million in Q1 2026 from $10.7 million in 2025.
  • Cash and cash equivalents grew to $55.7 million by March 31, 2026, from $33.6 million at end of 2025.
  • Selling and administrative expenses rose to $25.2 million in Q1 2026, up from $13.6 million in 2025.

The Final Word

Mobia has evolved from a research-focused entity into a commercial medical device provider for the stroke recovery market. The company’s 2026 public offering provides the capital needed to scale its sales infrastructure and clinical outreach.

AI Generated • Jun 5, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

167

CEO

Richard Foust

Website

www.mobia.com

Headquarters

Austin, TX 78738, US

MOBI Financials

Key Financial Metrics (TTM)

Gross Margin

80.59%

Operating Margin

-144.71%

Net Income Margin

-145.12%

Return on Equity

30.84%

Return on Capital

N/A

Return on Assets

-96.57%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$367.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

33.25M

Volume

3.03K

Avg. Volume

207.01K

Financials (TTM)

Gross Profit

$9.94M

Operating Income

-$16.94M

EBITDA

-$17.33M

Operating Cash Flow

-$17.73M

Capital Expenditure

-$42.00K

Free Cash Flow

-$17.77M

Cash & ST Invst.

$55.73M

Total Debt

$49.21M

Mobia Medical Performance Analysis

Mobia Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20242024-12-31USD 15,644,398N/A
20252025-12-31USD 32,040,978104.8%
Mobia Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12026-03-31N/A
Mobia Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20242024-12-31USD -0.74N/A
20252025-12-31USD -1.4189.0%
Mobia Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$12.07M

N/A

Gross Profit

$9.94M

N/A

Gross Margin

82.33%

N/A

Market Cap

$367.73MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.20M

N/A

Employees

167

N/A

Net Income

-$17.74M

N/A

EBITDA

-$17.33M

N/A

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$55.73M

N/A

Total Debt

$49.21M

N/A

Accounts Receivable

$4.85M

N/A

Inventory

$6.05M

N/A

Long Term Debt

$48.86M

N/A

Short Term Debt

$358.00K

N/A

Return on Assets

-96.57%

N/A

Return on Invested Capital

-1.22%

N/A

Free Cash Flow

-$17.77M

N/A

Operating Cash Flow

-$17.73M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,510.84+0.00%
^DJIDJI
$52,306.84+0.00%
^IXICNASDAQ
$25,750.82-0.00%
BTCBitcoin
$65,855.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$23.04+0.04%
SMCISuper Micro Computer
$30.56+0.20%
AALAmerican Airlines Group
$14.79-0.03%
NUNu Holdings
$14.51+0.01%

Questions About MOBI

What is the current price of Mobia Medical?

Mobia Medical is trading at $11.03 per share.

What is the 52-week range for Mobia Medical?

Over the past 52 weeks, Mobia Medical has traded between $10.19 and $15.29.

How much debt does Mobia Medical have?

As of the most recent reporting period, Mobia Medical reported total debt of $49.21M.

How much cash does Mobia Medical have on hand?

Mobia Medical reported $55.73M in cash and cash equivalents in its most recent financial results.

What is Mobia Medical’s dividend yield?

Mobia Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services